apr
22
Public Event
About Exhibition
World Orphan Drug Congress USA 2025 will take place from 22nd - 24th April 2025 at Boston Convention and Exhibition Center, Boston, Massachusetts, United States. This is a major event for anyone involved in rare diseases and orphan drugs. It focuses on rare diseases and orphan drugs, bringing together various stakeholders including pharmaceutical companies, patient advocacy groups, and regulators. It is expected to attract over 2,000 attendees from the pharmaceutical and biotechnology industry, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers.
World Orphan Drug Congress USA 2025 will take place from 22nd - 24th April 2025 at Boston Convention and Exhibition Center, Boston, Massachusetts, United States. This is a major event for anyone involved in rare diseases and orphan drugs. It focuses on rare diseases and orphan drugs, bringing together various stakeholders including pharmaceutical companies, patient advocacy groups, and regulators. It is expected to attract over 2,000 attendees from the pharmaceutical and biotechnology industry, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers.
22 apr 09:00 AM to 24 apr 06:00 PM
-
Our Story
The World Orphan Drug Congress USA is the defining event for the rare disease and orphan drug space globally. Widely regarded as the most important event for all rare disease stakeholders to attend, we are yet again bringing together top thought leaders from around the globe for a world-class event on April 22-24, 2025 in Boston, MA.
Over 3 days, you will have the opportunity to hear from 300+ speakers across, our 16 themes of content, engage in networking opportunities with over 2,000+ rare disease attendees, and meet with over 100+ exhibitors.
Each year, our event helps foster key collaborations for rare disease patients and orphan drug developers. The leading pharmaceutical and biotechnology companies, regulators, patient advocacy groups, payers, investors, and solution providers, all rely on the congress to convene and brainstorm ways to advance orphan drug development and improve access to life-saving therapies for rare disease patients.
Our team is looking forward to seeing you in Boston, MA on April 22-24, 2025 for another industry defining event.
See you in April, 2025!Our Story The World Orphan Drug Congress USA is the defining event for the rare disease and orphan drug space globally. Widely regarded as the most important event for all rare disease stakeholders to attend, we are yet again bringing together top thought leaders from around the globe for a world-class event on April 22-24, 2025 in Boston, MA. Over 3 days, you will have the opportunity to hear from 300+ speakers across, our 16 themes of content, engage in networking opportunities with over 2,000+ rare disease attendees, and meet with over 100+ exhibitors. Each year, our event helps foster key collaborations for rare disease patients and orphan drug developers. The leading pharmaceutical and biotechnology companies, regulators, patient advocacy groups, payers, investors, and solution providers, all rely on the congress to convene and brainstorm ways to advance orphan drug development and improve access to life-saving therapies for rare disease patients. Our team is looking forward to seeing you in Boston, MA on April 22-24, 2025 for another industry defining event. See you in April, 2025!
0 Reacties ·0 aandelen ·404 Views ·0 voorbeeld -
Breaking down silos and fostering collaboration to help rare disease patients
The World Orphan Drug Congress convenes top pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. This conference provides a forum to discuss and advance orphan drug development and enhance access to life-saving therapies for individuals living with a rare disease.
Join us in Boston for three days of the most comprehensive program and inclusive gathering of rare disease stakeholders.Breaking down silos and fostering collaboration to help rare disease patients The World Orphan Drug Congress convenes top pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. This conference provides a forum to discuss and advance orphan drug development and enhance access to life-saving therapies for individuals living with a rare disease. Join us in Boston for three days of the most comprehensive program and inclusive gathering of rare disease stakeholders.
0 Reacties ·0 aandelen ·478 Views ·0 voorbeeld
Meer blogs